{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:02:37Z","timestamp":1786978957365,"version":"build-2736575974"},"publisher-location":"Cham","reference-count":69,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319225418","type":"print"},{"value":"9783319225425","type":"electronic"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-22542-5_6","type":"book-chapter","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T06:38:24Z","timestamp":1445495904000},"page":"139-156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Hereditary Medullary Thyroid Cancer Genotype\u2013Phenotype Correlation"],"prefix":"10.1007","author":[{"given":"Karin","family":"Frank-Raue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedhelm","family":"Raue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,23]]},"reference":[{"issue":"4","key":"6_CR1","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1440-1827.2006.01942.x","volume":"56","author":"N Asai","year":"2006","unstructured":"Asai N, Jijiwa M, Enomoto A, Kawai K, Maeda K, Ichiahara M et al (2006) RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung\u2019s disease. Pathol Int 56(4):164\u2013172","journal-title":"Pathol Int"},{"issue":"11","key":"6_CR2","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1210\/jc.2005-0044","volume":"90","author":"J Barbet","year":"2005","unstructured":"Barbet J, Campion L, Kraeber-Bodere F, Chatal JF, Group GTES (2005) Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 90(11):6077\u20136084","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"6_CR3","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1373\/clinchem.2003.026963","volume":"50","author":"JP Basuyau","year":"2004","unstructured":"Basuyau JP, Mallet E, Leroy M, Brunelle P (2004) Reference intervals for serum calcitonin in men, women, and children. Clin Chem 50(10):1828\u20131830","journal-title":"Clin Chem"},{"issue":"3","key":"6_CR4","first-page":"770","volume":"83","author":"I Berndt","year":"1998","unstructured":"Berndt I, Reuter M, Saller B, Frank-Raue K, Groth P, Grussendorf M et al (1998) A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab 83(3):770\u2013774","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"6_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.14310\/horm.2002.1111011","volume":"6","author":"S Bethanis","year":"2007","unstructured":"Bethanis S, Koutsodontis G, Palouka T, Avgoustis C, Yannoukakos D, Bei T et al (2007) A newly detected mutation of the RET protooncogene in exon 8 as a cause of multiple endocrine neoplasia type 2A. Hormones 6(2):152\u2013156","journal-title":"Hormones"},{"issue":"12","key":"6_CR6","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86(12):5658\u20135671","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"6_CR7","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.surg.2008.08.028","volume":"144","author":"M Brauckhoff","year":"2008","unstructured":"Brauckhoff M, Machens A, Hess S, Lorenz K, Gimm O, Brauckhoff K et al (2008) Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: an exploratory analysis. Surgery 144(6):1044\u20131050 discussion 50\u20133","journal-title":"Surgery"},{"issue":"4","key":"6_CR8","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/SLA.0b013e3182a6f43a","volume":"259","author":"M Brauckhoff","year":"2014","unstructured":"Brauckhoff M, Machens A, Lorenz K, Bjoro T, Varhaug JE, Dralle H (2014) Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective. Ann Surg 259(4):800\u2013806","journal-title":"Ann Surg"},{"issue":"6","key":"6_CR9","first-page":"1076","volume":"55","author":"KM Carlson","year":"1994","unstructured":"Carlson KM, Bracamontes J, Jackson CE, Clark R, Lacroix A, Wells SA Jr et al (1994) Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am J Hum Genet 55(6):1076\u20131082","journal-title":"Am J Hum Genet"},{"issue":"3","key":"6_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/BF03347719","volume":"17","author":"I Ceccherini","year":"1994","unstructured":"Ceccherini I, Romei C, Barone V, Pacini F, Martino E, Loviselli A et al (1994) Identification of the Cys634\u2192Tyr mutation of the RET proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosis. J Endocrinol Invest 17(3):201\u2013204","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"6_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1530\/ERC-11-0117","volume":"18","author":"B Cosci","year":"2011","unstructured":"Cosci B, Vivaldi A, Romei C, Gemignani F, Landi S, Ciampi R et al (2011) In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer. Endocr Relat Cancer 18(5):603\u2013612","journal-title":"Endocr Relat Cancer"},{"issue":"20","key":"6_CR12","doi-asserted-by":"publisher","first-page":"10179","DOI":"10.1158\/0008-5472.CAN-06-0884","volume":"66","author":"AN Cranston","year":"2006","unstructured":"Cranston AN, Carniti C, Oakhill K, Radzio-Andzelm E, Stone EA, McCallion AS et al (2006) RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2B. Cancer Res 66(20):10179\u201310187","journal-title":"Cancer Res"},{"issue":"3","key":"6_CR13","doi-asserted-by":"publisher","first-page":"e18380","DOI":"10.1371\/journal.pone.0018380","volume":"6","author":"DK Crockett","year":"2011","unstructured":"Crockett DK, Piccolo SR, Ridge PG, Margraf RL, Lyon E, Williams MS et al (2011) Predicting phenotypic severity of uncertain gene variants in the RET proto-oncogene. PLoS ONE 6(3):e18380","journal-title":"PLoS ONE"},{"issue":"11","key":"6_CR14","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.1210\/jc.2003-030997","volume":"88","author":"AM Da Silva","year":"2003","unstructured":"Da Silva AM, Maciel RM, Da Silva MR, Toledo SR, De Carvalho MB, Cerutti JM (2003) A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma. J Clin Endocrinol Metab 88(11):5438\u20135443","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"6_CR15","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","volume":"2","author":"H Donis-Keller","year":"1993","unstructured":"Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC et al (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2(7):851\u2013856","journal-title":"Hum Mol Genet"},{"issue":"4","key":"6_CR16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1373\/clinchem.2004.045484","volume":"51","author":"G Eisenhofer","year":"2005","unstructured":"Eisenhofer G, Lenders JW, Goldstein DS, Mannelli M, Csako G, Walther MM et al (2005) Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Clin Chem 51(4):735\u2013744","journal-title":"Clin Chem"},{"issue":"12","key":"6_CR17","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1210\/jc.2007-1005","volume":"92","author":"R Elisei","year":"2007","unstructured":"Elisei R, Romei C, Cosci B, Agate L, Bottici V, Molinaro E et al (2007) RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. J Clin Endocrinol Metab 92(12):4725\u20134729","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"6_CR18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1210\/jc.2011-2046","volume":"97","author":"R Elisei","year":"2012","unstructured":"Elisei R, Romei C, Renzini G, Bottici V, Cosci B, Molinaro E et al (2012) The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18\u00a0years experience at one single center. J Clinical Endocrinol Metab 97(2):426\u2013435","journal-title":"J Clinical Endocrinol Metab"},{"issue":"4","key":"6_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000346174","volume":"1","author":"R Elisei","year":"2013","unstructured":"Elisei R, Alevizaki M, Conte-Devolx B, Frank-Raue K, Leite V, Williams GR (2013) 2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer. Eur Thyroid J 1(4):216\u2013231","journal-title":"Eur Thyroid J"},{"issue":"19","key":"6_CR20","first-page":"1575","volume":"276","author":"C Eng","year":"1996","unstructured":"Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF et al (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. Int RET Mutat Consortium Anal JAMA 276(19):1575\u20131579","journal-title":"Int RET Mutat Consortium Anal JAMA"},{"issue":"1","key":"6_CR21","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1210\/jc.2009-1728","volume":"95","author":"Z Erlic","year":"2010","unstructured":"Erlic Z, Hoffmann MM, Sullivan M, Franke G, Peczkowska M, Harsch I et al (2010) Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome. J Clin Endocrinol Metab 95(1):308\u2013313","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"6_CR22","first-page":"1780","volume":"81","author":"K Frank-Raue","year":"1996","unstructured":"Frank-Raue K, Hoppner W, Frilling A, Kotzerke J, Dralle H, Haase R et al (1996) Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group. J Clin Endocrinol Metab 81(5):1780\u20131783","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"6_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1530\/eje.1.02216","volume":"155","author":"K Frank-Raue","year":"2006","unstructured":"Frank-Raue K, Buhr H, Dralle H, Klar E, Senninger N, Weber T et al (2006) Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype. Eur J Endocrinol Eur Fed Endocr Soc 155(2):229\u2013236","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"issue":"5\u20136","key":"6_CR24","first-page":"273","volume":"53","author":"K Frank-Raue","year":"2007","unstructured":"Frank-Raue K, Rondot S, Schulze E, Raue F (2007) Change in the spectrum of RET mutations diagnosed between 1994 and 2006. Clin Lab 53(5\u20136):273\u2013282","journal-title":"Clin Lab"},{"issue":"2","key":"6_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-2265.2008.03215.x","volume":"69","author":"K Frank-Raue","year":"2008","unstructured":"Frank-Raue K, Machens A, Scheuba C, Niederle B, Dralle H, Raue F et al (2008) Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791. Clin Endocrinol 69(2):259\u2013263","journal-title":"Clin Endocrinol"},{"issue":"1","key":"6_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/humu.21385","volume":"32","author":"K Frank-Raue","year":"2011","unstructured":"Frank-Raue K, Rybicki LA, Erlic Z, Schweizer H, Winter A, Milos I et al (2011) Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. Hum Mutat 32(1):51\u201358","journal-title":"Hum Mutat"},{"issue":"10","key":"6_CR27","doi-asserted-by":"publisher","first-page":"802","DOI":"10.7326\/0003-4819-111-10-802","volume":"111","author":"RF Gagel","year":"1989","unstructured":"Gagel RF, Levy ML, Donovan DT, Alford BR, Wheeler T, Tschen JA (1989) Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis. Ann Intern Med 111(10):802\u2013806","journal-title":"Ann Intern Med"},{"issue":"6","key":"6_CR28","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1067\/msy.2002.128559","volume":"132","author":"O Gimm","year":"2002","unstructured":"Gimm O, Niederle BE, Weber T, Bockhorn M, Ukkat J, Brauckhoff M et al (2002) RET proto-oncogene mutations affecting codon 790\/791: a mild form of multiple endocrine neoplasia type 2A syndrome? Surgery 132(6):952\u2013959 discussion 9","journal-title":"Surgery"},{"issue":"2","key":"6_CR29","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1210\/jc.2003-031091","volume":"89","author":"I Ilias","year":"2004","unstructured":"Ilias I, Pacak K (2004) Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab 89(2):479\u2013491","journal-title":"J Clin Endocrinol Metab"},{"key":"6_CR30","doi-asserted-by":"crossref","unstructured":"Jasim S, Ying AK, Waguespack SG, Rich TA, Grubbs EG, Jimenez C et al (2011) Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. Thyroid 21(2):189\u2013192 (official journal of the American Thyroid Association)","DOI":"10.1089\/thy.2010.0328"},{"issue":"5","key":"6_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1365-2265.2006.02509.x","volume":"64","author":"P Kaldrymides","year":"2006","unstructured":"Kaldrymides P, Mytakidis N, Anagnostopoulos T, Vassiliou M, Tertipi A, Zahariou M et al (2006) A rare RET gene exon 8 mutation is found in two Greek kindreds with familial medullary thyroid carcinoma: implications for screening. Clin Endocrinol 64(5):561\u2013566","journal-title":"Clin Endocrinol"},{"key":"6_CR32","doi-asserted-by":"crossref","unstructured":"Kraimps JL, Denizot A, Carnaille B, Henry JF, Proye C, Bacourt F et al (1996) Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d\u2019Etude des Tumeurs a Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons. World J Surg 20(7):808\u2013812 (discussion 12\u20133)","DOI":"10.1007\/s002689900123"},{"key":"6_CR33","doi-asserted-by":"crossref","unstructured":"Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, et al American Thyroid Association Guidelines Task F (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19(6):565\u2013612 (official journal of the American Thyroid Association)","DOI":"10.1089\/thy.2008.0403"},{"issue":"16","key":"6_CR34","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJMoa012915","volume":"349","author":"A Machens","year":"2003","unstructured":"Machens A, Niccoli-Sire P, Hoegel J, Frank-Raue K, van Vroonhoven TJ, Roeher HD et al (2003) Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349(16):1517\u20131525","journal-title":"N Engl J Med"},{"issue":"2","key":"6_CR35","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/SLA.0b013e3181ae333f","volume":"250","author":"A Machens","year":"2009","unstructured":"Machens A, Lorenz K, Dralle H (2009) Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels. Ann Surg 250(2):305\u2013310","journal-title":"Ann Surg"},{"issue":"4","key":"6_CR36","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/humu.20928","volume":"30","author":"RL Margraf","year":"2009","unstructured":"Margraf RL, Crockett DK, Krautscheid PM, Seamons R, Calderon FR, Wittwer CT et al (2009) Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype\/phenotype correlations. Hum Mutat 30(4):548\u2013556","journal-title":"Hum Mutat"},{"issue":"6130","key":"6_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/328527a0","volume":"328","author":"CG Mathew","year":"1987","unstructured":"Mathew CG, Chin KS, Easton DF, Thorpe K, Carter C, Liou GI et al (1987) A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 328(6130):527\u2013528","journal-title":"Nature"},{"issue":"1","key":"6_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1210\/jcem.87.1.8136","volume":"87","author":"FH Menko","year":"2002","unstructured":"Menko FH, van der Luijt RB, de Valk IA, Toorians AW, Sepers JM, van Diest PJ et al (2002) Atypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918. J Clin Endocrinol Metab 87(1):393\u2013397","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"6_CR39","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1677\/ERC-08-0105","volume":"15","author":"IN Milos","year":"2008","unstructured":"Milos IN, Frank-Raue K, Wohllk N, Maia AL, Pusiol E, Patocs A et al (2008) Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC\u00a0>\u00a0TGG) mutation. Endocr Relat Cancer 15(4):1035\u20131041","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"6_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1349-7006.1999.tb00658.x","volume":"90","author":"A Miyauchi","year":"1999","unstructured":"Miyauchi A, Futami H, Hai N, Yokozawa T, Kuma K, Aoki N et al (1999) Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation. Jpn J Cancer Res Gann 90(1):1\u20135","journal-title":"Jpn J Cancer Res Gann"},{"key":"6_CR41","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/363458a0","volume":"363","author":"LM Mulligan","year":"1993","unstructured":"Mulligan LM, Kwok JB, Healey CS et al (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458\u2013460","journal-title":"Nature"},{"key":"6_CR42","doi-asserted-by":"crossref","unstructured":"Oliveira MN, Hemerly JP, Bastos AU, Tamanaha R, Latini FR, Camacho CP et al (2011) The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo. Thyroid 21(9):975\u2013985 (official journal of the American Thyroid Association)","DOI":"10.1089\/thy.2010.0190"},{"issue":"2","key":"6_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.14310\/horm.2002.1227","volume":"8","author":"K Pacak","year":"2009","unstructured":"Pacak K, Eisenhofer G, Ilias I (2009) Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome. Hormones 8(2):111\u2013116","journal-title":"Hormones"},{"issue":"6","key":"6_CR44","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1530\/EJE-08-0476","volume":"159","author":"M Peppa","year":"2008","unstructured":"Peppa M, Boutati E, Kamakari S, Pikounis V, Peros G, Panayiotides IG et al (2008) Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene. Eur J Endocrinol Eur Fed Endocr Soc 159(6):767\u2013771","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"issue":"6","key":"6_CR45","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.surg.2007.09.013","volume":"142","author":"FJ Quayle","year":"2007","unstructured":"Quayle FJ, Fialkowski EA, Benveniste R, Moley JF (2007) Pheochromocytoma penetrance varies by RET mutation in MEN 2A. Surgery 142(6):800\u2013805 discussion 5 e1","journal-title":"Surgery"},{"issue":"Suppl 1","key":"6_CR46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.6061\/clinics\/2012(Sup01)13","volume":"67","author":"F Raue","year":"2012","unstructured":"Raue F, Frank-Raue K (2012) Genotype-phenotype correlation in multiple endocrine neoplasia type 2. Clinics 67(Suppl 1):69\u201375","journal-title":"Clinics"},{"issue":"4","key":"6_CR47","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2796.1995.tb01212.x","volume":"238","author":"F Raue","year":"1995","unstructured":"Raue F, Kraimps JL, Dralle H, Cougard P, Proye C, Frilling A et al (1995) Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Intern Med 238(4):369\u2013373","journal-title":"J Intern Med"},{"key":"6_CR48","doi-asserted-by":"crossref","unstructured":"Rich TA, Feng L, Busaidy N, Cote GJ, Gagel RF, Hu M et al (2014) Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations. Thyroid 24(7):1096\u20131106 (official journal of the American Thyroid Association)","DOI":"10.1089\/thy.2013.0620"},{"issue":"3","key":"6_CR49","doi-asserted-by":"publisher","first-page":"E509","DOI":"10.1210\/jc.2010-1234","volume":"96","author":"V Rohmer","year":"2011","unstructured":"Rohmer V, Vidal-Trecan G, Bourdelot A, Niccoli P, Murat A, Wemeau JL et al (2011) Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d\u2019Etude des Tumeurs Endocrines. J Clin Endocrinol Metab 96(3):E509\u2013E518","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"6_CR50","first-page":"1619","volume":"81","author":"C Romei","year":"1996","unstructured":"Romei C, Elisei R, Pinchera A, Ceccherini I, Molinaro E, Mancusi F et al (1996) Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence. J Clin Endocrinol Metab 81(4):1619\u20131622","journal-title":"J Clin Endocrinol Metab"},{"key":"6_CR51","doi-asserted-by":"crossref","unstructured":"Romei C, Ugolini C, Cosci B, Torregrossa L, Vivaldi A, Ciampi R et al (2012) Low prevalence of the somatic M918t RET mutation in micro-medullary thyroid cancer. Thyroid 22: 476\u2013481 (official journal of the American Thyroid Association)","DOI":"10.1089\/thy.2011.0358"},{"key":"6_CR52","doi-asserted-by":"crossref","unstructured":"Rothberg AE, Raymond VM, Gruber SB, Sisson J (2009) Familial medullary thyroid carcinoma associated with cutaneous lichen amyloidosis. Thyroid 19(6):651\u2013655 (official journal of the American Thyroid Association)","DOI":"10.1089\/thy.2009.0021"},{"issue":"5196","key":"6_CR53","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1126\/science.7824936","volume":"267","author":"M Santoro","year":"1995","unstructured":"Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M et al (1995) Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267(5196):381\u2013383","journal-title":"Science"},{"issue":"6","key":"6_CR54","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1365-2265.2012.04462.x","volume":"77","author":"HL Sarika","year":"2012","unstructured":"Sarika HL, Papathoma A, Garofalaki M, Vasileiou V, Vlassopoulou B, Anastasiou E et al (2012) High prevalence of exon 8 G533C mutation in apparently sporadic medullary thyroid carcinoma in Greece. Clin Endocrinol 77(6):857\u2013862","journal-title":"Clin Endocrinol"},{"issue":"1","key":"6_CR55","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/1097-0215(20010120)95:1<62::AID-IJC1011>3.0.CO;2-1","volume":"95","author":"T Schilling","year":"2001","unstructured":"Schilling T, Burck J, Sinn HP, Clemens A, Otto HF, Hoppner W et al (2001) Prognostic value of codon 918 (ATG\u2192ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. Int J Cancer J Int du Cancer 95(1):62\u201366","journal-title":"Int J Cancer J Int du Cancer"},{"issue":"6","key":"6_CR56","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1097\/SLA.0b013e318237480c","volume":"254","author":"A Scholten","year":"2011","unstructured":"Scholten A, Valk GD, Ulfman D, Borel RIH, Vriens MR (2011) Unilateral subtotal adrenalectomy for pheochromocytoma in multiple endocrine neoplasia type 2 patients: a feasible surgical strategy. Ann Surg 254(6):1022\u20131027","journal-title":"Ann Surg"},{"issue":"2","key":"6_CR57","first-page":"487","volume":"83","author":"I Schuffenecker","year":"1998","unstructured":"Schuffenecker I, Virally-Monod M, Brohet R, Goldgar D, Conte-Devolx B, Leclerc L et al (1998) Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D\u2019etude des Tumeurs a Calcitonine. J Clin Endocrinol Metab 83(2):487\u2013491","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"6_CR58","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1687-9856-2012-25","volume":"2012","author":"RK Shankar","year":"2012","unstructured":"Shankar RK, Rutter MJ, Chernausek SD, Samuels PJ, Mo JQ, Rutter MM (2012) Medullary thyroid cancer in a 9-week-old infant with familial MEN 2B: Implications for timing of prophylactic thyroidectomy. Int J Pediatr Endocrinol 2012(1):25","journal-title":"Int J Pediatr Endocrinol"},{"issue":"10","key":"6_CR59","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/sj.onc.1201481","volume":"15","author":"DP Smith","year":"1997","unstructured":"Smith DP, Houghton C, Ponder BA (1997) Germline mutation of RET codon 883 in two cases of de novo MEN 2B. Oncogene 15(10):1213\u20131217","journal-title":"Oncogene"},{"issue":"3","key":"6_CR60","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/cen.12513","volume":"81","author":"D Taieb","year":"2014","unstructured":"Taieb D, Kebebew E, Castinetti F, Chen CC, Henry JF, Pacak K (2014) Diagnosis and preoperative imaging of multiple endocrine neoplasia type 2: current status and future directions. Clin Endocrinol 81(3):317\u2013328","journal-title":"Clin Endocrinol"},{"issue":"6","key":"6_CR61","first-page":"509","volume":"243","author":"M Takahashi","year":"1998","unstructured":"Takahashi M, Asai N, Iwashita T, Murakami H, Ito S (1998) Molecular mechanisms of development of multiple endocrine neoplasia 2 by RET mutations. J Intern Med 243(6):509\u2013513","journal-title":"J Intern Med"},{"issue":"1","key":"6_CR62","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1530\/ERC-14-0491","volume":"22","author":"RA Toledo","year":"2015","unstructured":"Toledo RA, Hatakana R, Lourenco DM Jr, Lindsey SC, Camacho CP, Almeida M et al (2015) Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility. Endocr Relat Cancer 22(1):65\u201376","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"6_CR63","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12020-009-9242-7","volume":"36","author":"E Vaclavikova","year":"2009","unstructured":"Vaclavikova E, Dvorakova S, Sykorova V, Bilek R, Dvorakova K, Vlcek P et al (2009) RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest. Endocrine 36(3):419\u2013424","journal-title":"Endocrine"},{"issue":"2","key":"6_CR64","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1046\/j.1365-2265.2003.01782.x","volume":"59","author":"U Verga","year":"2003","unstructured":"Verga U, Fugazzola L, Cambiaghi S, Pritelli C, Alessi E, Cortelazzi D et al (2003) Frequent association between MEN 2A and cutaneous lichen amyloidosis. Clin Endocrinol 59(2):156\u2013161","journal-title":"Clin Endocrinol"},{"issue":"1","key":"6_CR65","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000092848","volume":"66","author":"U Verga","year":"2006","unstructured":"Verga U, Morpurgo PS, Vaghi I, Radetti G, Beck-Peccoz P (2006) Normal range of calcitonin in children measured by a chemiluminescent two-site immunometric assay. Horm Res 66(1):17\u201320","journal-title":"Horm Res"},{"issue":"8","key":"6_CR66","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1210\/jc.2013-1204","volume":"98","author":"SA Wells Jr","year":"2013","unstructured":"Wells SA Jr, Pacini F, Robinson BG, Santoro M (2013) Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update. J. Clin. Endocrinol Metab 98(8):3149\u20133164","journal-title":"J. Clin. Endocrinol Metab"},{"key":"6_CR67","doi-asserted-by":"crossref","unstructured":"Wells SAA, S.L.; Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal SM, Santoro M, Schlumberger M, Shah M, Waguespack S (2015) Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma. Thyroid: official journal of the American Thyroid Association\u00a025(6):567\u2013610\u00a0","DOI":"10.1089\/thy.2014.0335"},{"issue":"8","key":"6_CR68","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/hmg\/3.8.1259","volume":"3","author":"J Zedenius","year":"1994","unstructured":"Zedenius J, Wallin G, Hamberger B, Nordenskjold M, Weber G, Larsson C (1994) Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s. Hum Mol Genet 3(8):1259\u20131262","journal-title":"Hum Mol Genet"},{"issue":"5","key":"6_CR69","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1530\/EJE-08-0854","volume":"160","author":"D Zenaty","year":"2009","unstructured":"Zenaty D, Aigrain Y, Peuchmaur M, Philippe-Chomette P, Baumann C, Cornelis F et al (2009) Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B. Eur J Endocrinol Eur Fed Endocr Soc 160(5):807\u2013813","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"}],"container-title":["Recent Results in Cancer Research","Medullary Thyroid Carcinoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-22542-5_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T08:57:43Z","timestamp":1676969863000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-22542-5_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9783319225418","9783319225425"],"references-count":69,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-22542-5_6","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"value":"0080-0015","type":"print"},{"value":"2197-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]},"assertion":[{"value":"23 October 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}